physician's lead manual fineline ii sterox · 2020-05-21 · 1 +0[(description)fineline™ ii...
TRANSCRIPT
PHYSICIAN'S LEAD MANUAL
Implantable Lead
FINELINE™ II STEROX
4456/4457/4458/4459/4479/4480
2016-03
91095046-01A
Boston Scientific FINELINE IMAGEREADY IROX
(DESCRIPTION) ................................................................ 1MR Conditional (MR Conditional System
Information) ...................................................................................1MRI (Implant-related MRI Conditions
of Use) ...........................................................................................1(Lead Features) .........................................................2
(INDICATIONS) ................................................................. 2(CONTRAINDICATIONS) .................................................. 2(WARNINGS) ..................................................................... 2
(PRECAUTIONS) ................................................ 3(General) ....................................................................3
(Handling) .............................................................................4(Implanting) .......................................................................4
(POTENTIAL ADVERSE EVENTS) .......... 5(IMPLANT INFORMATION) ..................... 7
(Precautions) ..............................................................7(Sterilization) ............................................................................7(Storage) ..................................................................................7
(Handling) .............................................................................7(Precautions) ...........................................................8
(General Information) .................................................8(Precautions) ...........................................................8
(Insertion Procedures) .......................................................8(Threshold Measurements) ...........................................9
(Securing the Lead) ................................................. 10(POSTIMPLANT) ...................................................... 12
(RETURNING EXPLANTED PRODUCTS) .... 12(SYMBOLS ON PACKAGING) ............................. 13
(SPECIFICATIONS) ......................................................... 14
1
(DESCRIPTION)FINELINE™ II4456 4457 4458 4459 4479 4480
MR Conditional (MR Conditional System Information)
MR ConditionalMRI
MRI ( MR Conditional) MR Conditional
ImageReady MR Conditional Pacing System MRI Technical Guide ImageReady MR Conditional Defibrillation System MRI Technical Guide (MRI Technical Guide )
MRIMR Conditional
Programmer/Recorder/Monitor (PRM) PRM MR Conditional
MRIMRI Technical Guide
MRI (Implant-related MRI Conditions of Use)MRI
MRIMRI
Technical Guide MR Conditional
2
(Lead Features)0.75mg
21
(IROX™)
IS-11
(INDICATIONS)(4456 4457
4458 4459) (4479 4480)
(CONTRAINDICATIONS)
• ( )• 0.75mg
(WARNINGS)
: MRIMRI Technical Guide
• MRI ( MRI Technical Guide )MRI
MR Conditional
MRIMRI Technical Guide
1. IS-1 ISO 5841-3:2013
3
• American College of Radiology Guidance Document for Safe MR Practices 2
Zone III MRI(
) MR ConditionalMRI MRI Zone
III IV•
•
•
• ( )
• 1
(PRECAUTIONS)(General)
•(7 " (Sterilization)" )
•
2. Kanal E, et al., American Journal of Roentgenology 188:1447-74, 2007.
4
: MR ConditionalMR Conditional
MR Conditional
MRIMRI Technical Guide
: MRIMRI
•
•
Physicians' Desk Reference™ 3
(Handling)•
••
•
(Implanting)•
•
•
3. Physicians' Desk Reference Thomson Healthcare Inc.
5
(POTENTIAL ADVERSE EVENTS)
( )
• (Air embolism)• (Allergic reaction)• (Arterial damage with subsequent
stenosis)• (Bleeding)• (Bradycardia)• (Breakage/failure of the
implant instruments)• (Cardiac perforation)• (Cardiac tamponade)• (Chronic nerve damage)• (Component failure)• (Conductor coil fracture)• (Death)• (Electrolyte imbalance/dehydration)• (Elevated thresholds)• (Erosion)• (Excessive fibrotic tissue growth)• ( ) (Extracardiac stimulation
(muscle/nerve stimulation))• (Fluid accumulation)• (Foreign body rejection phenomena)• (Formation of hematomas or seromas)• (Heart block)• (Hemorrhage)• (Hemothorax)• (Inability to pace)• ( : ATP )
(Inappropriate therapy (e.g., shocks and antitachycardia pacing [ATP] where applicable, pacing))
• (Incisional pain)
6
• (Incomplete lead connection with pulse generator)
• (Infection including endocarditis)• (Lead dislodgment)• (Lead fracture)• (Lead insulation breakage or
abrasion)• (Malignancy or skin
burn due to fluoroscopic radiation)• ( : ) (Myocardial trauma (e.g.,
tissue damage, valve damage))• (Myopotential sensing)• (Oversensing/
undersensing)• (Pericardial rub effusion)• (Pneumothorax)• (Pulse generator and/
or lead migration)• (Syncope)•
(Tachyarrhythmias, which include acceleration of arrhythmias and early, recurrent atrial fibrillation)
• (Thrombosis/thromboemboli)• (Valve damage)• (Vasovagal response)• (Venous occlusion)• ( : ) (Venous trauma (e.g.,
perforation, dissection, erosion))
MRIMRI MRI
Technical Guide
7
(IMPLANT INFORMATION)
: MR Conditional
MRIMRI Technical Guide
(Precautions)•
•
(Sterilization)
( 1 2)
(Storage)25°C(77°F) 15 30°C(59 86°F)
50°C(122°F)
(Handling)
8
(Precautions)•
••
•
(General Information)
() (
)
(7Fr )
(Precautions)•
(Insertion Procedures)
( )
( )(
3 )
( 4 )
9
2
(Atrial Placement)1. J
2.
3.J
(Ventricular Placement)1.
( 5)
2.
3.
(Threshold Measurements)
10
(Ventricular)500 0.6V 1.2mA
1.0V 2.0mA5.0mV
200 2000
(Atrial)500 1.0V 2.0mA
1.5V 3.0mA0.5 4.0mV
1.5mV200 2000
:
()
(Securing the Lead)
( 6 )
:•
•
11
1.( 1)
2. ( 2)
3. ( 3)
4.( 4)
12
5.( 5)
6.( 6)
(POSTIMPLANT)
(RETURNING EXPLANTED PRODUCTS):
:
13
(SYMBOLS ON PACKAGING)
CE
14
(SPECIFICATIONS)
MR Conditional
4479/4480 ( )4456/4457 ( )
4458/4459( )
( )7 Fr/2.3 mm 7 Fr/2.3 mm
(0.75 mg) (0.75 mg)
( )
1.9 mm (5.7 Fr) 1.9 mm (5.7 Fr)5 mm2 5 mm2
IROX ( ) IROX ( )( )a
( )31 mm2 33 mm2
16 mm 16 mm
( ) ( )
55D 80A4456: 52 cm4457: 58 cm4479: 45 cm4480: 52 cm
4458: 52 cm4459: 58 cm
1.7 mm (5 Fr) 2 mm (6 Fr)
15
40 4040 40
3.2 mm (IS-1b ) 3.2 mm (IS-1b)316L 316L
c 10 N 10 N
1.6 mm 1.6 mm2.7 mm 2.7 mm5 mm 5 mm
a. (PEG)
b. IS-1 ISO 5841-3:2013
c. Intermedics prEN45502-2 (1996 9 16 )
4479/4480 ( )4456/4457 ( )
4458/4459( )
16
www.bostonscientific.jp
© 2014 Boston Scientific or its affiliates.All Rights Reserved.
355403-222
II PU 4456/4457/4479/4480
II 4458/4459